Development of microscopic polyangiitis in patients with chronic airway disease

K Takahashi1, S Hayashi, O Ushiyama

  • 1Department of Medicine, Saga University Medical School, Nabeshima 5-1-1, Saga 849-8501, Japan. hayashs@cc.saga-u.ac.jp

Lung
|October 8, 2005
PubMed

Insights

Microscopic polyangiitis (MPA) with preceding chronic airway disease (CAD) presents differently and has a better survival rate. This suggests CAD may influence MPA development and clinical course.

Area of Science:

  • Rheumatology
  • Pulmonology
  • Internal Medicine

Background:

  • Microscopic polyangiitis (MPA) is a rare systemic vasculitis often associated with myeloperoxidase-specific antineutrophil cytoplasmic antibodies (MPO-ANCA).
  • Pulmonary manifestations typically include diffuse alveolar hemorrhage and interstitial pneumonia, but bronchiectasis has also been observed.

Purpose of the Study:

  • To investigate the clinical features of MPA patients, specifically comparing those with and without pre-existing chronic airway diseases (CAD).

Main Methods:

  • A retrospective observational study of 26 MPA patients over 13 years at Saga University Hospital.
  • Review of clinical records and radiological chest examinations (chest radiograph and CT).

Main Results:

  • Bronchiectasis was present in 35% of patients; 15% with bronchiectasis and 4% with chronic bronchitis had prior chronic bronchial suppuration.
  • 10 patients (38%) had pre-existing CAD. The CAD group had lower MPO-ANCA levels, no pulmonary hemorrhage or interstitial pneumonia, and significantly better 90-day survival (10% vs. 43.8%).

Conclusions:

  • Chronic airway disease may contribute to the development of MPA.
  • MPA in patients with CAD exhibits distinct clinical features and a more favorable prognosis compared to MPA without CAD.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...